Full text is available at the source.
DNA-triggered CRISPR/Cas12a circuit for highly sensitive and flexible biosensing
Updated
Abstract
The CBD biosensing platform achieves a detection limit of 14 CFU/mL for methicillin-resistant Staphylococcus aureus.
- A bulge DNA (BD)-driven activation circuit enhances the sensitivity of the CRISPR/Cas12a biosensing tool.
- For nucleic acid targets, the system initiates a positive feedback loop that amplifies detection signals.
- Detection of pesticides and mycotoxins is possible at the picogram-per-milliliter level through a universal single-stranded DNA activator.
- An 'OR' logic gate allows for simultaneous detection of two mycotoxins, demonstrating multiplexing capabilities.
- The CBD platform shows versatility for both nucleic acid and non-nucleic acid target detection.
Simplified